Nektar Therapeutics (NKTR) Description, Stock price, News & Info.

#ThinkSabio Latest News

Nektar Therapeutics Announces Completion of Target Enrollment in REZOLVE-AD Phase 2b Clinical Trial of Rezpegaldesleukin in Patients with Moderate-to-Severe Atopic Dermatitis